| Literature DB >> 31372493 |
Rima Kandil1, Yuran Xie2, Ralf Heermann3, Lorenz Isert1, Kirsten Jung4, Aditi Mehta1, Olivia M Merkel1.
Abstract
RNA interference (RNAi) offers the potential to selectively silence disease-related genes in defined cell subsets. Translation into the clinical routine is, however, still hampered by the lack of efficient carrier systems for therapeutic siRNA, endosomal entrapment presenting a major hurdle. A promising siRNA delivery system has previously been developed on the base of polyethylenimine (PEI) and the targeting ligand transferrin (Tf) to specifically reach activated T cells in the lung. In the present work, the focus is on optimizing Tf-PEI polyplexes for gene knockdown in primary activated T cells by improving their endosomal escape properties. Blending of the conjugate with membrane lytic melittin significantly enhanced endosomal release and thereby cytoplasmic delivery, while maintaining selective T cell targeting abilities and overall cell tolerability. The gathered data furthermore demonstrate that melittin addition also distinctly improves several other essential particle characteristics, such as siRNA encapsulation efficiency and stability in lung lining fluids. In conclusion, this results in a novel upgraded siRNA delivery system that is not only able to specifically deliver its payload to the desired target cells via receptor-mediated endocytosis, but also shows enhanced release from endosomal vesicles in order to initiate RNAi in the cytoplasm.Entities:
Keywords: T cell targeting; endosomal escape; melittin; siRNA delivery; transferrin receptors
Year: 2019 PMID: 31372493 PMCID: PMC6675603 DOI: 10.1002/adtp.201900047
Source DB: PubMed Journal: Adv Ther (Weinh) ISSN: 2366-3987